| IMRX | PRESS-RELEASE | neutral | 4/10 | Immuneering issued a press release commenting on the recent FDA approval of a new second-line pancreatic cancer treatmen | Aug 26, 2026 |
| GMED | PRESS-RELEASE | neutral | 4/10 | Globus Medical announced the acquisition of Higgs Boson Health, a digital healthcare experience company incubated at Duk | Aug 26, 2026 |
| NVDA | PRESS-RELEASE | bullish | 6/10 | NVIDIA and AWS announced a major expansion of their strategic collaboration, including plans to deploy 2 million additio | Aug 26, 2026 |
| VRRM | PRESS-RELEASE | neutral | 3/10 | Verra Mobility announced a five-year contract renewal and expansion of its technology partnership with Hertz, including | Aug 26, 2026 |
| PXS | PRESS-RELEASE | neutral | 2/10 | Pyxis Tankers Inc. announced a press release, but the provided document content is synthetic and contains no financial d | Aug 26, 2026 |
| RVSB | PRESS-RELEASE | neutral | 4/10 | Riverview Bancorp announced a $4.0 million stock repurchase program and authorized a Rule 10b5-1 trading plan with Raymo | Aug 26, 2026 |
| AAME | PRESS-RELEASE | bearish | 7/10 | Atlantic American Corporation received a Nasdaq delisting notice for failing to file its Q2 2026 Form 10-Q, remaining de | Aug 26, 2026 |
| PRMB | PRESS-RELEASE | neutral | 5/10 | No summary provided | Aug 26, 2026 |
| GEG | PRESS-RELEASE | bearish | 6/10 | Great Elm Group reported a fiscal Q4 2026 net income of $1.1M on revenue of $10.6M (+88% YoY), but a full-year net loss | Aug 26, 2026 |
| AME | PRESS-RELEASE | bullish | 7/10 | AMETEK completed its $5.0 billion all-cash acquisition of Indicor Instrumentation, a portfolio of mission-critical indus | Aug 26, 2026 |
| URBN | PRESS-RELEASE | bullish | 5/10 | Urban Outfitters reported Q2 FY2027 adjusted EPS of $1.72, a 0.9% beat vs. the $1.70 consensus, and record revenue of $1 | Aug 26, 2026 |
| HPQ | PRESS-RELEASE | bullish | 7/10 | HPQ reported fiscal Q3 2026 non-GAAP diluted EPS of $0.83, beating consensus of $0.69 by 20.3%, and revenue of $15.7B (+ | Aug 26, 2026 |
| LTRX | PRESS-RELEASE | neutral | 5/10 | Lantronix reported fiscal Q4 2026 revenue of $31.2M, up 8% YoY, and non-GAAP EPS of $0.04, in line with consensus. GAAP | Aug 26, 2026 |
| NVDA | PRESS-RELEASE | bullish | 7/10 | NVIDIA reported Q2 FY27 revenue of $96.2B (up 106% YoY) and non-GAAP EPS of $2.22, beating consensus estimates of $92.18 | Aug 26, 2026 |
| VEEV | PRESS-RELEASE | bullish | 7/10 | Veeva Systems reported fiscal Q2 2027 results that exceeded guidance on all metrics, with total revenue of $928.0M (+18% | Aug 26, 2026 |
| P | PRESS-RELEASE | neutral | 5/10 | No summary provided | Aug 26, 2026 |
| AWK | PRESS-RELEASE | neutral | 2/10 | American Water Charitable Foundation awarded a $25,000 Workforce Readiness grant to Monterey Peninsula College Foundatio | Aug 26, 2026 |
| TOWN | PRESS-RELEASE | neutral | 2/10 | TowneBank declared a Q3 2026 cash dividend of $0.28 per common share, payable October 9, 2026. This is a routine quarter | Aug 26, 2026 |
| FNUC | PRESS-RELEASE | neutral | 2/10 | Frontier Nuclear and Minerals Inc. held its 2026 Annual General & Special Meeting, where shareholders elected six direct | Aug 26, 2026 |
| CYCU | PRESS-RELEASE | bearish | 7/10 | Cycurion reported Q1 2026 EPS of -$0.47, a massive 840% miss vs the -$0.05 consensus, with revenue of $4.4M. The CEO's l | Aug 26, 2026 |
| RVMD | PRESS-RELEASE | bullish | 8/10 | Revolution Medicines received FDA approval for RASONQUE (daraxonrasib) for metastatic pancreatic adenocarcinoma after at | Aug 26, 2026 |
| DE | PRESS-RELEASE | neutral | 2/10 | No summary provided | Aug 26, 2026 |
| CYCU | PRESS-RELEASE | neutral | 4/10 | Cycurion (CYCU) announced a 1-for-8 reverse stock split effective August 28, 2026, to regain compliance with Nasdaq's mi | Aug 26, 2026 |
| ASNS | PRESS-RELEASE | neutral | 2/10 | Actelis Networks participated in AFCEA TechNet Augusta, engaging with U.S. Army organizations and federal systems integr | Aug 26, 2026 |
| ROIV | PRESS-RELEASE | bullish | 6/10 | Priovant Therapeutics (a Roivant company) published skin-specific outcomes from the Phase 3 VALOR trial of brepocitinib | Aug 26, 2026 |
| SFL | PRESS-RELEASE | neutral | 1/10 | SFL Corporation announced it will host a conference call on August 26, 2026 to discuss its Q2 2026 results. | Aug 26, 2026 |
| INNV | PRESS-RELEASE | neutral | 1/10 | InnovAge announced it will host a conference call on September 8, 2026 to discuss its fiscal Q4 2026 results. | Aug 26, 2026 |
| BBIO | PRESS-RELEASE | bullish | 7/10 | BridgeBio announced first patient dosed in ASCEND-ATTR, a Phase 3b/4 study of acoramidis in ATTR-CM, designed to assess | Aug 26, 2026 |
| SFL | PRESS-RELEASE | neutral | 5/10 | SFL reported Q2 2026 net income of $34M ($0.25 EPS) on $201M revenue, with adjusted EBITDA of $130M. The company declare | Aug 26, 2026 |
| EUDA | PRESS-RELEASE | neutral | 2/10 | EUDA Health subsidiary Melana International won the SME100 Awards 2026 Singapore, a non-financial recognition for its pr | Aug 26, 2026 |